NFKB1 and depressive symptom measurement: Leng et al. demonstrated that NF-κB activity was significantly elevated in depression-like mice, and inhibition of NF-κB resulted in alleviation of depression-like behaviors, indicating the pathway’s potential role in MDD [42].